MicroRNA 155 Expression and Treatment Response in Toxoplasma gondii-Infected Psoriasis Patients
Biochemical markers play a role in determining the response to pyrimethamine treatment; however, other factors may also contribute. Future research should focus on larger longitudinal studies to validate these findings and explore additional biomarkers.
Authors
- Manar Ezzelarab Ramadan (ORCID: https://orcid.org/0000-0002-9688-5602)
- Doaa Ghaith
- Hany N. Azzam
- Sherief Abd‐Elsalam (ORCID: https://orcid.org/0000-0003-4366-2218)
- Maysa I. Farghly (ORCID: https://orcid.org/0009-0006-3226-9372)
- Eman Ahmed (ORCID: https://orcid.org/0000-0001-7959-1998)
- Nesreen Hamdy Mahmoud (ORCID: https://orcid.org/0000-0002-2401-6651)
- Abdullah D. Alanazi (ORCID: https://orcid.org/0000-0002-4862-7668)
- Maha S. Hussein (ORCID: https://orcid.org/0000-0002-3369-2635)
- Heba Aboelela
- Reem Elmahdy (ORCID: https://orcid.org/0009-0006-7120-4467)
- Amal Ahmed Mohamed (ORCID: https://orcid.org/0000-0001-5294-2081)
- Samar S. Khalaf (ORCID: https://orcid.org/0000-0003-4986-8567)
- Hany Sleem
Institutions
- Suez Canal University (EG)
- Suez University (EG)
- Cairo University (EG)
- Benha University (EG)
- Tanta University (EG)
- Heliopolis University (EG)
- Tanta University Hospital (EG)
- Ministry of Health (AE)
- National Water Research Center (EG)
- National Heart Institute (EG)
- Helwan University (EG)
Publication Details
- Journal
- Infectious Disorders - Drug Targets
- Published
- 2025-08-05
- DOI
- https://doi.org/10.2174/0118715265369365250715020937
- Primary Topic
- Toxoplasma gondii Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00